Literature DB >> 19924773

2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Frederick G Kushner, Mary Hand, Sidney C Smith, Spencer B King, Jeffrey L Anderson, Elliott M Antman, Steven R Bailey, Eric R Bates, James C Blankenship, Donald E Casey, Lee A Green, Alice K Jacobs, Judith S Hochman, Harlan M Krumholz, Douglass A Morrison, Joseph P Ornato, David L Pearle, Eric D Peterson, Michael A Sloan, Patrick L Whitlow, David O Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19924773     DOI： 10.1002/ccd.22351

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


× No keyword cloud information.
  17 in total

1.  Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response.

Authors:  J P Lewis; A S Fisch; K Ryan; J R O'Connell; Q Gibson; B D Mitchell; H Shen; K Tanner; R B Horenstein; R Pakzy; U S Tantry; K P Bliden; P A Gurbel; A R Shuldiner
Journal:  Clin Pharmacol Ther       Date:  2011-08-31       Impact factor: 6.875

2.  Risk Factors for Post-Coronary Artery Bypass Grafting (CABG) Atrial Fibrillation and the Role of Aspirin and Beta Blockers in its Prevention.

Authors:  Muhammad F Khan; Aravind Herle; Mohammad Reza Movahed
Journal:  J Atr Fibrillation       Date:  2013-02-12

3.  Benefits of Laparoscopic Surgery for Bleeding Events in Patients with Implantable Left Ventricular Assist Devices during Antithrombotic Therapy.

Authors:  Aya Nakae; Michiko Kodama; Eiji Kobayashi; Kae Hashimoto; Yuji Tominaga; Tadashi Kimura
Journal:  Gynecol Minim Invasive Ther       Date:  2022-05-04

4.  Comparison of clinical risk scores for triaging high-risk chest pain patients at the emergency department.

Authors:  Salah S Al-Zaiti; Ziad Faramand; Mohammad O Alrawashdeh; Susan M Sereika; Christian Martin-Gill; Clifton Callaway
Journal:  Am J Emerg Med       Date:  2018-06-08       Impact factor: 2.469

5.  Reporting of quality indicators and improvement in hospital performance: the P.Re.Val.E. Regional Outcome Evaluation Program.

Authors:  Cristina Renzi; Chiara Sorge; Danilo Fusco; Nera Agabiti; Marina Davoli; Carlo A Perucci
Journal:  Health Serv Res       Date:  2012-03-30       Impact factor: 3.402

6.  Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.

Authors:  Joshua P Lewis; Kathleen Ryan; Jeffrey R O'Connell; Richard B Horenstein; Coleen M Damcott; Quince Gibson; Toni I Pollin; Braxton D Mitchell; Amber L Beitelshees; Ruth Pakzy; Keith Tanner; Afshin Parsa; Udaya S Tantry; Kevin P Bliden; Wendy S Post; Nauder Faraday; William Herzog; Yan Gong; Carl J Pepine; Julie A Johnson; Paul A Gurbel; Alan R Shuldiner
Journal:  Circ Cardiovasc Genet       Date:  2013-02-07

7.  Diabetes and hyperglycemia in the critical care setting: has the evidence for glycemic control vanished? (Or … is going away?).

Authors:  Amy E Wagstaff; N Wah Cheung
Journal:  Curr Diab Rep       Date:  2014-01       Impact factor: 4.810

8.  Comparison of one-year clinical outcomes between intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stents for left main lesions: a single-center analysis of a 1,016-patient cohort.

Authors:  Xiao-Fei Gao; Jing Kan; Yao-Jun Zhang; Jun-Jie Zhang; Nai-Liang Tian; Fei Ye; Zhen Ge; Ping-Xi Xiao; Feng Chen; Gary Mintz; Shao-Liang Chen
Journal:  Patient Prefer Adherence       Date:  2014-09-23       Impact factor: 2.711

9.  P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.

Authors:  Michelle A Berny-Lang; Joseph A Jakubowski; Atsuhiro Sugidachi; Marc R Barnard; Alan D Michelson; Andrew L Frelinger
Journal:  J Am Heart Assoc       Date:  2013-05-15       Impact factor: 5.501

10.  Antiplatelet agents and proton pump inhibitors - personalizing treatment.

Authors:  Eugene Lin; Rajiv Padmanabhan; Majaz Moonis
Journal:  Pharmgenomics Pers Med       Date:  2010-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.